D K Whynes

The NHS internal market: economic aspects of its medium-term development.

D. Whynes, D K Whynes, 1993, The International journal of health planning and management.

Responsiveness of the EQ-5D health-related quality-of-life instrument in assessing low back pain.

J G Hardman, D. Whynes, D K Whynes, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up

C M Mangham, J D Hardcastle, S. Moss, 2011, Gut.

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening

N J Wald, D M Hansell, D. Hansell, 2015, Thorax.

The Costs of Treating Breast Cancer in the United Kingdom: Implications for Screening

D. Whynes, J. Wolstenholme, D K Whynes, 1998, International Journal of Technology Assessment in Health Care.

Stage-specific treatment costs for cervical cancer in the United Kingdom.

D. Whynes, J. Wolstenholme, D K Whynes, 1998, European journal of cancer.

GP fundholding and the costs of prescribing.

D. Whynes, K. Tolley, D K Whynes, 1995, Journal of public health medicine.

Population screening for colorectal cancer: the implications of an ageing population

S. Moss, M. Waller, J. Scholefield, 2008, British Journal of Cancer.

Willingness-to-pay for colorectal cancer screening.

D. Whynes, E. Frew, J. Wolstenholme, 2001, European journal of cancer.